PRAKOTHARN
MR. DENCHAI, comes from Thailand, was diagnosed with colorectal cancer stage
III after recurrence of bloody stool in 2013. On the advice of doctor, MR.
DENCHAI underwent resection of colorectal tumor. In mid-2015, metastasis and
recurrence occurred. The Ct scans turned out that there was a tumor in his
liver and the size was about 3.5cm*3cm. After nanoknife in Modern CancerHospital Guangzhou, his condition is well under control and the tumor marker
has almost backed to normal. The symptoms including fatigue have also
disappeared.
MR.
DENCHAI(the third on the left) with
medical staff in MCHG
Bloody Stool: Typical Symptom of Colorectal Cancer
MR.
DENCHAI is 43 years old this year (2016). Symptom of bloody stool occurred to
him since 2008. Bloody stool is a typical symptom that occurs when colorectalcancer developed to a certain stage. However most people neglect the symptom as
bleeding caused by internal piles and even doctors would make misdiagnosis. In
fact, colorectal cancer, featuring high incidence rate and death rate,
frequently occurs among people over 45. Therefore it is necessary to take promptly
colorectal cancer screening as soon as the symptom of bloody stool occurs.
After the
occurrence of bloody stool, MR. DENCHAI didn’t take it serious. Until being
diagnosed with sigmoid colorectal cancer in a regular check-up, he was in
depressed mood and then undertook tumor removal on the doctor’s
suggestion.
Minimally
invasive specialist in MCGH, Director Bai Haishan was performing puncture and
placing electrode probes for the patient
One month
after the surgery, MR. DENCHAI began to undergo chemotherapy which uses chemo
drugs to kill cancer cells all over the body and may cause serious side
effects. Indeed, MR. DENCHAI terribly
suffered from severe hiccup after chemotherapy. “Every day I belched around the
clock, which affected eating and sleeping.” Being unbearable to the side
effects of chemotherapy, MR. DENCHAI gave up after two sessions of treatment.
Finally, he got to know MCHG through a Thailand advertisement. Minimally
invasive treatment taking advantages of few side effects caught his eyes and
gave him hope. Therefore he went to Guangzhou for treatment.
Nanoknife
Got Tumor Promptly Under Control.
In MCHG, MR. DENCHAI confirmed the diagnosis, recurrence and
metastasis of colorectal cancer stage IV after radical resection. For his
hepatic metastatic tumor, Multi-Disciplinary Team (MDT)
from MCHG immediately held a discussion. Since it was a single lesion, some
doctors wondered whether surgery was feasible. The lesion was located between
the right branch of portal vein and right hepatic artery. Applying removal
surgery might cause damage to these tissues and also might have high risk.
Ultimately after two-hour discussion, Multi-Disciplinary Team (MDT) decided to apply
the most advanced technique nanoknife to Mr. DENCHAI.
During
the nanoknife treatment
Nanoknife is a brand new, advanced tumor ablation therapy,
which breaks the membrane of tumor cells with high voltage pulses from
electrode probes, resulting in multiple permanent nano-meters Irreversible
Electroporation (IRE), damaging cells balance and accelerating the death of
cancer cells. The advantages of nanoknife far outweigh traditional
surgery such as, no damage to important tissues around the tumor, reservation
of vessels, bile duct, nerve, ureter, etc , distinct border of ablation area, reducing the
recurrence risk and achieving same therapeutic effect as usual operation.
Electric
probes releasing high-voltage pulses to break the membrane of tumor cells
After the treatment, MR. DENCHAI’s tumor got promptly under
control. In addition, he was free from side effects as before such as, nausea
and vomiting. He got soon rid of weak condition and regained optimism and
confidence. According to the chief physician Ma Xiaoying, currently MR.
DENCHAI’s tumor marker has almost backed to normal and he is in good
condition.
MR.
DENCHAI in good condition after treatment
Nanoknife-New Hope for Middle and Advanced Stage Cancer Patients
It is known that nanoknife has
been approved by US FDA into clinical use Ministry of Public Health of China
approved the technology for cancer treatment in 2015. It is a brand new
ablation therapy for solid tumor occurred in liver and pancreas.
Director Bai Haishan in Modern Cancer Hospital Guangzhou pointed
out that nanoknife applied in clinic
these years has brought hope to pancreatic cancer and hepatic cancer patients.
It enables patients with inoperable condition to achieve a chance of radical
therapeutic effect. “Especially for those tumors adjacent to main blood
vessels, doctors can’t do anything in the past. Patients always can just
passively wait for the fate. But now, these small probes can effectively avoid
surgical risk.”
The successful completion of nonaknife for recurrence of
colorectal cancer with liver metastasis means Modern Cancer Hospital Guangzhou
has made great progress in the field of nanoknife, which will bring more new
hope for the middle and advanced stage cancer patients.
没有评论:
发表评论